Tentarix Biotherapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Tentarix is reimagining biologics with conditionally active multispecifics that activate only in diseased tissue—improving efficacy while reducing toxicity. Our platform has attracted partnerships with AbbVie and Gilead and is advancing a wholly owned pipeline toward the clinic. With strong funding and near-term milestones, we’re positioned to move fast and welcome conversations with partners and investors who share our vision.